Little is known about the significance of the many clusters and syndromes that currently sit under the umbrella of 'Long Covid' or 'Post-covid'. Research is ongoing into the prevalence, management and long term prognosis of post-covid syndromes in adults and children. Meanwhile different measurement criteria used by studies undertaken so far make comparisons difficult and pose challenges for future rehabilitation, treatment and vaccination policies
A free webinar for clinicians, researchers and policymakers do discuss the emerging evidence about 'Long covid'
4.00 Welcome Fi Godlee (The BMJ)
MC Phil Hammond (Private Eye)
4.05 ‘What is 'long covid'/ post-covid?
(Chair: George Davey Smith, University of Bristol)
- Elaine Maxwell (NIHR)
- Jo House (University of Bristol) on patient perspectives
- Laura Spinney (science journalist and author) on the longterm health effects of 1918 ('Spanish@ flu
4.25 International Experience: What and where are the best data?
(Chair: Fi Godlee BMJ)
- Ben Humberstone and Daniel Ayoubkhani (ONS) : UK
- Simone Benatti : Italy
(see also Maxime Taquet in the next session)
4.50 Prognosis/available treatments and rehabilitation
(Chair: Allyson Pollock, Newcastle University)
- Melissa Heightman (UCL) on clinician service development
- Maxime Taquet (Oxford University) on the US data
- Margaret McCartney (GP) and Richard Byng (GP) on the primary care perspective
- Liz Whittaker (Imperial) on children and the CLOCK study
- Rob Barker Davis (Royal Air Force) on the value of exercise
5.45 Discussion and questions (chair: Phil Hammond)